Evaluation of Oral Pentoxifylline, Colchicine, and Penile Traction for the Management of Peyronie's Disease.
Colchicine
Erectile Dysfunction
Penile Traction
Pentoxifylline
Peyronie’s Disease
Journal
Sexual medicine
ISSN: 2050-1161
Titre abrégé: Sex Med
Pays: England
ID NLM: 101631053
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
18
04
2019
revised:
18
07
2019
accepted:
22
07
2019
pubmed:
26
8
2019
medline:
26
8
2019
entrez:
26
8
2019
Statut:
ppublish
Résumé
Currently, there are several treatment options for Peyronie disease (PD). Although surgical interventions have better reported outcomes than conservative therapy, surgery is not suitable for all patients with PD. Therefore, oral therapy for PD is still a frequently used treatment due to low cost, convenience and limited side effects. However, current literature on the efficacy of oral therapy in PD is inconclusive. Pentoxifylline and colchicine have both shown some promise though further studies are required to confirm their effectiveness. The aim of this study was to assess the efficacy of oral therapy for PD, including pentoxifylline and colchicine, coupled with the Andropenis penile traction therapy (PTT) extender on degree of penile curvature and plaque size. Between March 2015 and June 2018, a prospectively collected database for patients receiving oral therapy for PD (pentoxifylline and/or colchicine) was reviewed. Collected data variables were compared at baseline and after 6 months of treatment, including degree of curvature, plaque size, and penile Doppler ultrasound parameters (peak systolic velocity, minimum diastolic velocity, and pulsatility index). PTT was applied by the patient for a total of 1 hour per day for 6 months. A total of 46 patients were involved in this study. Mean age was 56 ± 10 years. There was a significant decrease in the degree of penile curvature after 6 months (55.8º ± 20º vs 41.4º ± 20.8º; P = .03). Likewise, the plaque size decreased significantly from 5.42 ± 2.7 to 2.42 ± 1.71 cm Altogether, pentoxifylline and colchicine, taken with concomitant PTT, present a potentially convenient, low cost, and effective treatment for penile curvature and plaque resulting from PD. Prospective randomized trials are still required for better evaluation of the course of PD with patients undergoing conservative management. Ibrahim A, Gazzard L, Alharbi M, et al. Evaluation of Oral Pentoxifylline, Colchicine, and Penile Traction for the Management of Peyronie's Disease. Sex Med 2019;7:459-463.
Identifiants
pubmed: 31445974
pii: S2050-1161(19)30092-3
doi: 10.1016/j.esxm.2019.07.003
pmc: PMC6963116
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
459-463Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Références
J Androl. 2009 Jul-Aug;30(4):397-405
pubmed: 18974422
J Sex Med. 2009 Feb;6(2):558-66
pubmed: 19138361
Int J Impot Res. 2004 Jun;16(3):238-43
pubmed: 14973528
J Sex Med. 2012 Jan;9(1):288-95
pubmed: 22024053
Adv Urol. 2011;2011:282503
pubmed: 22110491
BJU Int. 2003 Apr;91(6):522-4
pubmed: 12656907
BJU Int. 2010 Jul;106(2):240-8
pubmed: 19863517
Eur Urol. 2006 Aug;50(2):196-8
pubmed: 16759790
BJU Int. 2014 Jul;114(1):16-24
pubmed: 24447536
Urology. 2004 Aug;64(2):399-404
pubmed: 15302515
Expert Opin Pharmacother. 2011 Apr;12(6):931-44
pubmed: 21405946
J Urol. 2019 Apr;201(4):777-782
pubmed: 30672843
Nat Clin Pract Urol. 2006 Feb;3(2):111-5; quiz 116
pubmed: 16470210
Urology. 1994 Aug;44(2):291-5
pubmed: 8048212
Int J Impot Res. 2002 Oct;14(5):379-83
pubmed: 12454689
Eur Urol. 2001 Nov;40(5):525-30
pubmed: 11752860